Zusammenfassung
Das Auftreten von Bakterien, die resistent gegen antibakteriell wirkende Substanzen wie Antibiotika und Chemotherapeutika sind, ist ein seit der Entdeckung der ersten Antibiotika bekanntes Phänomen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
World Health Report 1998 (WHO, Genf).
Christ W (1998) Entwicklungen und Trends auf dem Gebiet der Antibiotika — Gibt es neue Wirkprinzipien? ßundesgesundhbl 41: 111–116.
Georges P (1987) Treatment and prevention of Haemophilus influenzae type b meningitis. Pediatr Infect Dis 6:787–790.
Campos J, Garcia-Tornel S, Sanfeliu I (1984) Susceptibility studies of multiple resistant Haemophilus influenzae isolated from pediatric patients and contacts. Antimicrob Agents Chemother 25:706–709.
von Kries R, Heinrich B, Böhm O, Windfuhr A, Helwig H (1997) Systemische Haemophilus influenzae-Erkrankungen in Deutschland: 1992–1995. Monatsschr Kinderheilkd 145: 136–143.
Kirschner W, Koch J (1995) Durchimpfungs grade und Impfverhalten bei Kindern in West-und Ostdeutschland im Jahr 1994. Robert Koch-Institut (Hrsg) InfFo IV, pp 10-16.
Siedler S, von Kries R, Lütticken R, Reinert RR (1998) Nationwide Study on Systemic Pneumoccocal Infections among children in Germany 1997. Kongreßband, Pneumoccocal Vaccines for the World 1998 Conference, 12–140 ktober, Washington DC, USA, S 52.
Robert Koch-Institut (Hrsg) (1998) Bakterielle Meningitis in Deutschland 1997. Epidemiologisches Bulletin 12/98, pp 79-81.
Prevention of Pneumococcal Disease, Recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR1997;46:No.RR-8,1-24.
Fedson DS (1997) Clinical Practice and Public Policy For Pneumococcal Vaccination: The Case for Germany. Presented at the Paul-Ehrlich-Institut, 6. Februar 1997 Langen, Germany.
Butler JC, Hofmann J, Cetron MS, Elliott JA, Facklam RR, Breiman RF (1996) The continued emergence of drug-resistant Streptococcus pneumonieae in the United States: an update from the Center for Disease Control and Prevention’s Pneumococcal Sentinel Surveillance System. J Infect Dis 174: 986–993.
Defining the Public Health Impact of Drug-Resistant Streptococcus pmeumoniae: Report of a Working Group. MMWR 1996;45:No.RR-5,1-20.
Klugman KP (1998) Antimicrobial Resistance. Kongreßband, Pneumoccocal Vaccines for the World 1998 Conference, 12–14 Oktober, Washington DC, USA, pp 13.
Klugmann KP (1990) Pneumococcal resistance to antibiotics. Clin Microbiol Rev 3: 171–196.
Dagan R, Givon N, Sjkolnik L, Yagupsky P, Fraser D (1998) Coverage by 7, 9 and 11 valent Pneumococcal Conjugate Vaccines (Pnc-V) of Otitis Media (OM) Pathogens in Israel. Kongreßband, Pneumoccocal Vaccines for the World 1998 Conference, 12–14 Oktober, Washington DC, USA, p 27.
Finland M (1979) Pneumonia and Pneumococcal Infections with special reference to pneumococcal pneumonia. Am Rev Respir Dis 120:481–502.
Brown EJ, Hosea SW, Hammer CH (1982) A quantitative analysis of the interactions of antiprneumococcal antibody and complement in experimental pneumococcal bacteriaemia. J Clin Invest 69:85–98.
Forester HL, Jahnigen DW, LaForce FM (1987) Inefficacy of pneumococcal vaccine in a high-risk population. Am J Med 83:425–430.
Ortquist A, Hedlund J, Burman LA, Elbel E, Höfer M, Leinonen M, Lindblad I, Sundelof B, Kalin M (1998) Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Lancet 351:399–403.
Robert Koch-Institut (Hrsg) (1998) Impfempfehlungen der Ständigen Impf kommission (STIKO) am Robert-Koch-Institut. Stand: März 1998. Epidemiologisches Bulletin 15/98, (http://www.rki.de
Black S, Shinefield H, Ray P, Lewis E, Fireman B (1998) Efficacy of Heptavalent Conjugate Pneumococcal Vaccine (Wyeth Lederle) in 37 000 Infants and Children: Results of the Northern California Kaiser Permanente Trial. Kongreßband, Pneumoccocal Vaccines for the World 1998 Conference, 12–14 Oktober, Washington DC, USA, p 18.
Eskola J, Kilpi T, Lankinene K, Haapakoski J, Eerola M, Takala A, Kayhty H (1998) Finnish Trial of Two Pneumococcal conjugate Vaccines Against Acute Otitis Media. Kongreßband, Pneumoccocal Vaccines for the World 1998 Conference, 12–14 Oktober, Washington DC, USA, p 20.
Edwards KM, White S, Wandling G, Palmer P, Cullay B, Decker MD (1998) High Rates of Nasopharyngeal Colonization with Resistant Pneumococci in Infants Attending A Private Pédiatric Practice. Kongreßband, Pneumoccocal Vaccines for the World 1998 Conference, 12–14 Oktober, Washington DC, USA, 28.
Ungureanu V, Pana M, Gheorghe M, Vrinceanu G (1998) Study of the Sensitivity to Antimicrobial Drugs of Some Streptococcus Pneummaoniae Strains isolated from Different Pathological States. Kongreßband, Pneumoccocal Vaccines for the World 1998 Conference, 12–14 Oktober, Washington DC, USA, p 51.
Hermans PWM, Sluijter M, de Groot R (1998) Frequent Horizontal Transfer of Pneumococcal Capsular Genes: A Threat fo Conjugate Vaccine Strategies? Kongreßband, Pneumoccocal Vaccines for the World 1998 Conference, 12–14 Oktober, Washington DC, USA, p 73.
Robert Koch-Institut (Hrsg) (1998) Kampf gegen die Tuberkulose notwendiger denn je. Epidemiologisches Bulletin 12/98, p 81.
Robert Koch-Institut (Hrsg) (1998) Tuberkulose-Situation in Deutschland 1997. Epidemiologisches Bulletin 16/98, pp 113-114.
Robert Koch-Institut (Hrsg) (1998) Zur Arzneimittelresistenz von M. tuberculosis in Deutschland. Epidemiologisches Bulletin 36/98, p 256.
ACIP (1988) Use of BCG Vaccines in the Control of Tuberculosis: A Joint Statement by the ACIP and the Advisory Committee for Elimination of Tuberculsosis. MMWR 37: 663–664, 669-675.
The role of BCG Vaccine in the Prevention and Control of Tuberculosis in the United States. MMWR July 1996.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Öppling, V. (1999). Einsatz bakterieller Impfstoffe beim Menschen. In: Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-38283-7_11
Download citation
DOI: https://doi.org/10.1007/978-3-662-38283-7_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-37515-0
Online ISBN: 978-3-662-38283-7
eBook Packages: Springer Book Archive